DCM Shriram reported a 22% rise in Q2 FY27 revenue to Rs 3,977 crore, driven by growth in Chemicals, Vinyl, and Fenesta segments. Despite top-line expansion, PBDIT fell to Rs 319 crore from Rs 408 crore due to higher input costs and the absence of prior-year one-time incentives. The board declared a 200% interim dividend, and the company is progressing with its planned demerger within the next 2-3 quarters.
DCM Shriram Q2 FY27: Revenue Rises 22% as Margins Face Input Cost Headwinds
Revenue grew by 22% YoY to Rs 3,977 crore, while PBDIT declined to Rs 319 crore from Rs 408 crore.
Reader Takeaway: Strong volume growth across core segments is currently being offset by high energy costs and lower margins.
What just happened
DCM Shriram has posted its financial results for the quarter ended September 30, 2026. The company saw robust top-line growth across several divisions, including Chemicals, Vinyl, Fertilizers, and its premium building brand, Fenesta. However, the operating profit (PBDIT) faced pressure, dropping roughly 22% compared to the same quarter last year. This decline is largely attributed to volatile input costs and the absence of Rs 91.5 crore in one-time benefits that boosted the previous year’s figures.
Why this matters
For investors, the results highlight a tug-of-war between volume-led growth and margin volatility. While businesses like Vinyl and Sugar & Ethanol showed improved profitability, the Chemicals segment—a major revenue contributor—saw margins compressed by rising raw material prices. The management’s focus on captive renewable power aims to mitigate these energy-intensive cost pressures over the next 12 months.
Corporate Actions and Projects
The company is aggressively scaling its infrastructure. This quarter saw the commissioning of a 100 TPD Aluminium Chloride plant and a 68 MW hybrid renewable power project. Additionally, the Board has declared a 200% interim dividend, reflecting steady cash flow despite the profit dip. The much-anticipated demerger of business units remains on track, with the management targeting completion within the next two to three quarters.
Risks to watch
Key risks remain in the form of geopolitical instability and fluctuating energy costs, which account for up to 70% of operating expenses in certain segments. The Bioseed business also remains a concern, recording a negative PBDIT of Rs 41 crore this quarter due to climate-related issues and inventory write-offs.
What to track next
- Progress on the demerger timeline.
- Capacity utilization ramp-up of the new Calcium Chloride facility.
- The impact of expanded renewable energy capacity on overall power costs.